Limits on costs and values of anticancer drugs in metastatic colorectal cancer: Policies and proposal.

被引：0
|
作者：
Guirgis, Helmy M. [1 ]
机构：
[1] Univ Calif Irvine, Orange, CA 92668 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 04期
关键词：
D O I：
10.1200/jco.2016.34.4_suppl.607
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
607
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Treatment pathways and associated costs of metastatic colorectal cancer in Greece
    Ioannis Sougklakos
    Elias Athanasiadis
    Ioannis Boukovinas
    Michalis Karamouzis
    Aggelos Koutras
    Paulos Papakotoulas
    Dimitra Latsou
    Magda Hatzikou
    Eugena Stamuli
    Athanasios Balasopoulos
    Aggelos Sideris
    Cost Effectiveness and Resource Allocation, 20
  • [22] SURVEY AND ANALYSIS OF THE COSTS OF METASTATIC COLORECTAL CANCER TREATMENT IN SERBIA
    Rutkowski, J.
    Haldas, M.
    Jedynasty, K.
    VALUE IN HEALTH, 2010, 13 (07) : A262 - A263
  • [23] Costs and consequences of different chemotherapy regimens in metastatic colorectal cancer
    Hale, JP
    Cohen, DR
    Maughan, TS
    Stephens, RJ
    BRITISH JOURNAL OF CANCER, 2002, 86 (11) : 1684 - 1690
  • [24] Costs and consequences of different chemotherapy regimens in metastatic colorectal cancer
    J P Hale
    D R Cohen
    T S Maughan
    R J Stephens
    British Journal of Cancer, 2002, 86 : 1684 - 1690
  • [25] Treatment pathways and associated costs of metastatic colorectal cancer in Greece
    Sougklakos, Ioannis
    Athanasiadis, Elias
    Boukovinas, Ioannis
    Karamouzis, Michalis
    Koutras, Aggelos
    Papakotoulas, Paulos
    Latsou, Dimitra
    Hatzikou, Magda
    Stamuli, Eugena
    Balasopoulos, Athanasios
    Sideris, Aggelos
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2022, 20 (01)
  • [26] Impact of New Drugs and Biologics on Colorectal Cancer Treatment and Costs
    Karaca-Mandic, Pinar
    McCullough, Jeffrey S.
    Siddiqui, Mustaqeem A.
    Van Houten, Holly
    Shah, Nilay D.
    AMERICAN JOURNAL OF MANAGED CARE, 2011, 17 (05): : E160 - E168
  • [27] Impact of New Drugs and Biologics on Colorectal Cancer Treatment and Costs
    Karaca-Mandic, Pinar
    McCullough, Jeffrey S.
    Siddiqui, Mustaqeem A.
    Van Houten, Holly
    Shah, Nilay D.
    JOURNAL OF ONCOLOGY PRACTICE, 2011, 7 (03) : E30S - E37S
  • [28] IMPACT OF NEW DRUGS AND BIOLOGICALS ON TREATMENT AND COSTS FOR COLORECTAL CANCER
    Shah, N. D.
    Van Houten, H.
    Vermeulen, L.
    VALUE IN HEALTH, 2009, 12 (03) : A56 - A56
  • [29] Combination of irinotecan and other drugs in the treatment of colorectal metastatic cancer
    Ducreux, M
    Gil-Delgado, M
    André, T
    Ychou, M
    de Gramond, A
    Khayat, D
    BULLETIN DU CANCER, 1998, : 43 - 46
  • [30] Extending Limits of Resection for Metastatic Colorectal Cancer: Risk Benefit Ratio
    Yang, Anthony D.
    Brouquet, Antoine
    Vauthey, Jean Nicolas
    JOURNAL OF SURGICAL ONCOLOGY, 2010, 102 (08) : 996 - 1001
12345